Hints and tips:
Related Special Reports
...The applications backlog stood at more than 52,000 as of the end of last year, compared with fewer than 1,000 in 2012, according to data from the Institute of Legacy Management....
...T-Therapeutics is the latest commercial venture by geneticist Bradley, who is a former director of the Wellcome Sanger Institute, the UK’s largest genomic sequencing centre....
...Growing up in Lake Jackson, Texas, near a massive Dow Chemical factory where his father worked as a chemist, Anderson studied chemical engineering at the University of Texas at Austin and Massachusetts Institute...
...cigarette makers from the early 1980s onwards led to payouts and culminated in the 2000 master settlement in which four tobacco companies paid out $206bn to 46 states for suppressing smoking’s link to lung cancer...
...Gilead has worked with scientists at Accelerated Clinical Trials Ltd to develop a blood cancer treatment....
...The money raised by the appeal would be used to support the Francis Crick Institute, the global cancer research initiative Cancer Grand Challenges and innovation that would translate into effective therapies...
...The National Institute for Health and Care Excellence announced on Tuesday that it would not approve the medication Enhertu, developed by pharmaceutical companies Daiichi Sankyo and AstraZeneca, to treat...
...“It’s important to realise just how broad these illnesses are,” said Zandi, a researcher at University College London’s Queen Square Institute of Neurology....
...“Whole genome sequencing can be used as a single test to decide which drugs a cancer patient could benefit from,” said Trevor Graham, professor of genomics and evolution at London’s Institute of Cancer Research...
...Similarly, Sir Paul Nurse, another Nobel laureate who now leads the Francis Crick Institute in London, revealed how curiosity-driven studies of yeast cells are furnishing breast cancer therapies....
...Nick Davies, programme director at the Institute for Government think-tank, said: “The NHS faces huge problems, none of which can be fixed in a week.”...
...This study shows we are even further off track than we thought,” said the study’s lead author, Sarah Jackson of UCL’s institute of epidemiology and health....
...People lost more “healthy life years” to the syndrome in the first two years after infection than they would to cancer or heart disease, according to a study published in August....
...She was involved for decades with the National Institutes of Health (NIH) in Washington, DC, also working with the Breast Cancer Taskforce at the National Cancer Institute of the NIH, the Harvard School...
...On Thursday, I visited the Institute Curie in Paris to discuss how our AI tools could help with their pioneering work on some of the most serious forms of cancer....
...The fact that AI is better at spotting some cancers than humans, for example, makes some radiologists nervous about their role....
...CRUK has launched a joint research initiative with the US National Cancer Institute to learn more about the causes of early onset cancer. The trend has economic, clinical and social implications....
...He went on to inoculate cancer patients with live bacteria, saving some but killing others....
...Researchers have relied on funding from bodies such as the US National Institutes of Health (NIH) and the UK’s National Institute for Health and Care Research. Now, the money is drying up....
...For example, in the treatment of breast cancer, the US National Cancer Institute publishes guidelines for treatment devised by experts based on well-controlled studies that span decades, data needed because...
...In the 2021-22 financial year, about 92 per cent of cancer drugs submitted to the National Institute for Health and Care Excellence, which assesses value for money, were approved, compared with 60 per cent...
...It was notable that the Office for Budget Responsibility did not adjust it’s Brexit impacts forecast this week; while last week the National Institute of Economic and Social Research published an updated...
...The country’s National Institute for Health and Care Excellence, the public health body, recommends the drug be used only for people with serious underlying health conditions such as cancer and HIV or recipients...
...Johnson & Johnson struck a $2bn deal to buy Ambrx Biopharma, which specialises in antibody-drug conjugates, one of the hottest areas in cancer treatment....
...at London’s Francis Crick Institute....
International Edition